Bone turnover markers to explain changes in lumbar spine BMD with abaloparatide and teriparatide: results from ACTIVE.

Eastell, R. orcid.org/0000-0002-0323-3366, Mitlak, B.H., Wang, Y. et al. (3 more authors) (2019) Bone turnover markers to explain changes in lumbar spine BMD with abaloparatide and teriparatide: results from ACTIVE. Osteoporosis International, 30 (3). pp. 667-673. ISSN 0937-941X

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © The Author(s) 2019. This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Keywords: Abaloparatide; Bone mineral density; Bone turnover markers; Procollagen type I N propeptide; Teriparatide; Uncoupling index
Dates:
  • Accepted: 5 December 2018
  • Published (online): 11 January 2019
  • Published: 5 March 2019
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 18 Feb 2019 13:57
Last Modified: 16 Nov 2021 11:49
Status: Published
Publisher: Springer Nature
Refereed: Yes
Identification Number: https://doi.org/10.1007/s00198-018-04819-1
Related URLs:

Share / Export

Statistics